B-type natriuretic peptide is not a volume marker among patients on hemodialysis | Zendy

Rajiv Agarwal | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

B-type natriuretic peptide is not a volume marker among patients on hemodialysis

Author(s) -

Rajiv Agarwal

Publication year - 2013

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gft054

Subject(s) - medicine , hemodialysis , natriuretic peptide , biomarker , brain natriuretic peptide , cardiology , blood pressure , kidney disease , intravascular volume status , end stage renal disease , endocrinology , heart failure , biochemistry , chemistry

Although the cardiac biomarker B-type natriuretic peptide (BNP) is strongly related to mortality in end-stage renal disease (ESRD), whether it is a predictor of weight change or blood pressure (BP) response upon probing dry weight among hypertensive hemodialysis patients remains unknown. The purpose of this study was to examine among people with hypertension on hemodialysis whether BNP is a biomarker of excess volume.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research